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Yap Controls Stem/Progenitor Cell Proliferation in the
Mouse Postnatal Epidermis
Annemiek Beverdam1, Christina Claxton1, Xiaomeng Zhang2,3,4, Gregory James1, Kieran F. Harvey2,3,4 and
Brian Key1
Tissue renewal is an ongoing process in the epithelium of the skin. We have begun to examine the genetic
mechanisms that control stem/progenitor cell activation in the postnatal epidermis. The conserved Hippo
pathway regulates stem cell turnover in arthropods through to vertebrates. Here we show that its downstream
effector, yes-associated protein (YAP), is active in the stem/progenitor cells of the postnatal epidermis.
Overexpression of a C-terminally truncated YAP mutant in the basal epidermis of transgenic mice caused
marked expansion of epidermal stem/progenitor cell populations. Our data suggest that the C-terminus of YAP
controls the balance between stem/progenitor cell proliferation and differentiation in the postnatal interfollicular
epidermis. We conclude that YAP functions as a molecular switch of stem/progenitor cell activation in the
epidermis. Moreover, our results highlight YAP as a possible therapeutic target for diseases such as skin cancer,
psoriasis, and epidermolysis bullosa.
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INTRODUCTION
Perturbations to epidermal basal stem/progenitor proliferation
result in unbalanced epidermal homeostasis and devastating
diseases such as skin cancer, psoriasis, and epidermolysis
bullosa. yes-associated protein (YAP) has been identified in a
transcriptional profiling screen as a ‘‘stemness’’ gene
(Ramalho-Santos et al., 2002). It is a transcriptional
coactivator that is regulated by the highly conserved Hippo
pathway to control tissue homeostasis (Harvey and Tapon,
2007). In mammals, the core of this pathway consists of
several negative growth regulators acting in a kinase cascade,
including MST1/2 and its regulatory protein SAV, which
ultimately phosphorylates YAP serine residue 127 (S127-
phospho-YAP), causing inactivation through cytoplasmic
retention (Dong et al., 2007). Unphosphorylated YAP
translocates to the nucleus where it interacts with the TEAD
transcription factors to activate target gene transcription and
cell proliferation (Ota and Sasaki, 2008; Wu et al., 2008;
Zhang et al., 2008b; Zhao et al., 2008).
Gain- and loss-of-function mice have shown that the Hippo
pathway and Yap are critical regulators of organ size in vivo
(Camargo et al., 2007; Dong et al., 2007; Zhou et al., 2009; Lu
et al., 2010; Song et al., 2010; Schlegelmilch et al., 2011;
Zhang et al., 2011a; Zhou et al., 2011). Deregulation of
Hippo/YAP signaling has been implicated in tumorigenesis,
and Yap is generally considered to be a potent oncogene in
both mice and humans (reviewed by Chan et al., 2011).
Interestingly, high nuclear YAP expression in human cancer
was shown to correlate with poor prognosis (Xu et al., 2009;
Hall et al., 2010; Wang et al., 2010; Zhang et al., 2011b).
We have overexpressed a mutant form of YAP in transgenic
mice to examine the function of this ‘‘stemness’’ gene
specifically in epidermal homeostasis. We found a severe
expansion of the epidermal stem/progenitor cell compartments
and progressive postnatal alopecia that involved coat and
whiskers. Our data support a role of YAP in epidermal stem/
progenitor cell proliferation through regions in its N-terminus,
including the TEAD-binding domain. In contrast, the balance
between proliferation and differentiation in the interfollicular
epidermis appears to be dependent on the C-terminal YAP
regions, including YAP transactivation domain. We conclude
that YAP is a key regulator that lies at the crossroads of
proliferation, differentiation, and homeostatic maintenance in
the pathway controlling the cytoarchitecture of epidermis.
RESULTS AND DISCUSSION
YAP is expressed in proliferative zones of the skin
Initially, we investigated YAP expression in the epidermis of
wild-type mice (at postnatal day 85, P85; Figure 1). Using a
pan-YAP antibody, we detected prominent YAP expression in
the bulge of the proximal hair follicle and in the interfollicular
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epidermis (Figure 1a). YAP was clearly detected in the
cytoplasm of basal cells in the interfollicular epidermis and
in the bulge (arrows, Figure 1b–c). A similar expression pattern
was observed for S127-phosphorylated YAP (Figure 1d–f),
providing evidence that the Hippo pathway was functional
in these cells to control YAP activity. Both antibodies revealed
that YAP was present at relatively low levels along the outer
root sheaths of hair follicles and at high levels in the bulge
regions. The expression was mostly localized to the cytosol,
consistent with recent reports of the reduced nuclear localiza-
tion of YAP in skin during the perinatal period (Zhang et al.,
2011a). Immunostaining for the intermediate filament protein
Keratin 14, a marker of bulge and basal epidermal cells (Fuchs
and Green, 1980), was very similar to the YAP expression
pattern in the skin (Figure 1g–i). Together, this immunostaining
expression data suggest that the Hippo pathway and YAP may
have a role in postnatal epidermal tissue homeostasis.
Manipulating YAP activity perturbs skin maturation
We next manipulated endogenous YAP activity in the epider-
mis in vivo by transgenesis. We exploited a previously
generated mutant YAP protein ‘‘YAP2-5SA-DC’’ that is insen-
sitive to the Hippo pathway–induced cytoplasmic localization
because it lacks the serine residues, which are normally
phosphorylated (Hoshino et al., 2006; Zhao et al., 2007).
This YAP variant also lacks region C-terminal from Q281,
including a transactivation domain, which prevents it from
activating gene expression in vitro. YAP2-5SA-DC was forcibly
expressed in the basal stem/progenitor cells of the epidermis in
transgenic mice from 13.5 dpc onward (shortly after the onset
of epidermal stratification), using a bovine Keratin 5 promoter
fragment (Ramirez et al., 1994). We anticipated that this
mutant protein would block endogenous YAP function and
disrupt tissue homeostasis. We obtained five independent
YAP2-5SA-DC transgenic mouse lines displaying identical
epidermal phenotypes. Quantitative real-time PCR assays
confirmed high expression levels of the transgene in the skin
of P85 YAP2-5SA-DC transgenic mice, whereas endogenous
Yap expression levels were not different from wild-type skin.
Newborn YAP2-5SA-DC transgenic mice were healthy and
grossly indistinguishable from their wild-type littermates. At
P7, although the skin of YAP2-5SA-DC transgenic mice
became dry and scaly, their pelage developed similarly to
that of wild-type littermates. From 4–5 weeks of age, coincid-
ing with the second postnatal anagen phase (Muller-Rover
et al., 1999), the transgenic mice developed progressive dorsal
alopecia usually starting dorsally and gradually spreading out
across the body and resulting in complete baldness. The
transgenic mice also lost many of their whiskers (P106 wild-
type and transgenic littermates shown in Figure 2). The
affected skin regions were very dry and lost pliability. Skin
lesions developed, possibly because of excessive scratching,
but usually healed very rapidly (boxed inserts, Figure 2).
Despite this abnormal skin phenotype, we did not observe
any clear signs of tumor formation in the epidermis of
transgenic mice up to 1 year of age.
Altered skin histogenesis in YAP2-5SA-DC transgenic mice
The histology of newborn YAP2-5SA-DC transgenic epidermis
appeared similar in comparison with wild-type animals
(Figure 3a and b). However, Keratin 14 immunostaining
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Figure 1. YAP is expressed in the proliferative zones of the epidermis.
(a–i) Immunofluoresence staining in sections through the dorsal skin of P89
wild-type mice detecting pan-YAP (a–c), phospho-Serine127 YAP (P-YAP)
(d–f), and basal cell marker Keratin 14 (g–i). Arrows point at YAP expression in
basal cells in b and in bulge cells in c. Asterisks mark hair shafts. Basement
membranes are demarcated by dashed lines. DAPI, 40,6-diamidino-2-
phenylindole; IFE, interfollicular epidermis; YAP, yes-associated protein. Scale
bars¼ 100mm.
Wild-type YAP2-5SA-ΔC
P106
Figure 2. Progressive dorsal alopecia in YAP2-5SA-DC transgenic mice.
1x wild-type (left) and 3x YAP2-5SA-DC transgenic (right) P106 littermates.
Note that transgenic animals display alopecia and loss of whiskers. Affected
regions of dorsal skin of each transgenic mouse are magnified and displayed at
bottom of the figure.
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revealed initial signs of regional irregularities in the thickness
of the basal stem/progenitor cell layer of the transgenic
interfollicular epidermis (arrows, Figure 3d and 3c). At P10,
during the first postnatal anagen phase, we detected local
thickenings of the interfollicular epidermis (opposing arrows in
Figure 3F with similar region in Figure 3e). The hair follicles at
this age appeared similar in control and transgenic animals
(dotted outlines, Figure 3e and f). There was no discernable
difference in the histological appearance of the dermal papilla,
matrix, or precortex in the hair bulb (Figure 3k and l). At P49,
shortly after the onset of hair loss in transgenic mice, both the
interfollicular epidermis (opposing arrows in Figure 3h) and
the outer root sheaths were clearly thicker (opposing arrows in
Figure 3g and h), whereas the hair bulbs were relatively
normal (Figure 3m and n). By P85, the interfollicular epidermis
of YAP2-5SA-DC transgenic mice was now markedly thick-
ened (Figure 3i and j; also see thickness increase between
Figure 3f, 3h, and 3j). Moreover, the sebaceous glands in hair
follicles were grossly enlarged (asterisks in Figure 3j). Hair
follicles in YAP2-5SA-DC adult mice did appear to undergo
anagen, although the cycling proximal hair follicles extended
highly abnormal rudimentary cell masses into the dermis
(single arrows in Figure 3j), which lacked hair shafts or
obvious signs of hair bulb structures such as the dermal
papillae or matrix cells (Figure 3o and p). This aberrant
morphology probably accounts for the alopecia in transgenic
animals.
Next, we examined the cellular constituency of the inter-
follicular epidermis of P85 wild-type and YAP2-5SA-DC
littermates in more detail. Immunostaining revealed a marked
expansion of the Keratin 14–expressing basal cell populations
in the interfollicular epidermis and hair follicles of transgenic
mice (Figure 4a and b). The Keratin 10–expressing spinous
layer (Figure 4c and d) and involucrin-expressing granular
layer (Figure 4e and f) also had clearly thickened in transgenic
animals compared with wild-type animals. In addition, loricrin
staining revealed a thickening of the cornified layer, indicative
of hyperkeratinization in the transgenic animals (Figure 3g and
h). To assess whether cell proliferation patterns in the
epidermis were affected by expression of the transgene, we
immunostained tissue sections for the expression of the mitosis
marker phospho-histone H3 (Hans and Dimitrov, 2001). Only
small numbers of dividing nuclei were present in the basal
layer of the wild-type interfollicular epidermis, whereas large
numbers of dividing nuclei were detected throughout both
basal and suprabasal layers of the YAP2-5SA-DC interfollicular
epidermis (arrows in Figure 3i and j). We counted mitotic
nuclei and found B20-fold higher numbers of proliferating
cells in the YAP2-5SA-DC transgenic epidermis compared
with wild-type P85 epidermis (n¼3, data not shown). To
assess the identity of these dividing cells, we performed
immunostaining assays with epidermal progenitor cell marker,
P63 (Hans and Dimitrov, 2001), and found that in wild-type
epidermis, the progenitor cells were typically localized to the
basal layer of the interfollicular epidermis (arrows, Figure 3k).
In contrast, the P63-expressing progenitor cell population had
expanded and was now clearly present in both basal and
suprabasal layers in the YAP2-5SA-DC interfollicular epider-
mis (arrows, Figure 3l). Together, these data suggest that the
overexpression of YAP2-5SA-DC in postnatal epidermis
resulted in hyperproliferation of the basal stem/progenitor cell
population and an expansion of the principal cell layers of the
interfollicular epidermis.
Next, we turned our attention to the cellular constituency of
the P85 anagen hair follicles. In wild-type follicles, Keratin 14
is discretely expressed in the outer root sheath cells that
surround the hair shaft (Figure 5a). In the absence of the hair
shaft in transgenic animals, the Keratin 14–expressing cell
populations appear to have expanded and form an elongated
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Figure 3. Ontology of the epidermal phenotype in YAP2-5SA-DC transgenic
mice. H&E (a, b, e–p) and Keratin 14 immunostaining assays (c, d) of wild-type
(a, c, e, g, i, k, m, o) and YAP2-5SA-DC transgenic (b, d, f, h, j, l, n, p) skin of
P0 (a–d), P10 (e, f, k, l), P49 (g, h, m, n), and P85 (i, j, o, p) littermates. Single
white arrows in d point at irregularities in the basal layer of P0 YAP2-5SA-DC
transgenic epidermis. Opposing arrows in e–j highlight thickness of the
interfollicular epidermis. Opposing arrowheads in g, h highlight the thickness
of the hair follicle shaft. Single arrows in j point at expanded cell masses in hair
follicles of P85 YAP2-5SA-DC transgenic skin. Asterisks in j mark enlarged
sebaceous glands. Basement membranes are demarcated by dashed lines.
DAPI, 40,6-diamidino-2-phenylindole; DP, dermal papilla; H&E, hematoxylin
and eosin staining; Mx, matrix; PCX, precortex. Scale bars¼ 100mm.
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and irregular-shaped tail or strand of cells (arrows in
Figure 5b). The expression of Keratin 6 is usually restricted
to the companion layer of the hair follicles (Figure 5c), and it is
upregulated in hyperproliferative epidermal cells (Winter
et al., 1998). We could not identify Keratin 6 expression
reminiscent of the companion layer in the interfollicular
epidermis of the YAP2-5SA-DC transgenic mice, but it was
highly expressed in discrete proliferative cell masses in the
hair follicles (arrows in Figure 5d and f), as well as in the
suprainfundibular hair shafts and interfollicular epidermis of
the YAP2-5SA-DC transgenic mice (above dashed lines in
Figure 5d), consistent with the increased cell proliferation
previously shown (Figure 4j). Interestingly, the proliferative
cell masses located in the abnormal proximal hair follicles
also expressed hair follicle bulge stem/progenitor cell markers
Keratin 15 (Figure 5g with Figure 5h; Liu et al., 2003), SOX9
(Figure 5i with Figure 5j; Vidal et al., 2005), LHX2 (Figure 5k
with Figure 5l; Rhee et al., 2006), and CD34 (Figure 5m with
Figure 5n; Trempus et al., 2003). These data show that the
bulge stem/progenitor cell populations have markedly
expanded in the YAP2-5SA-DC transgenic mice.
Next, we wanted to determine whether the hair germ was
present in the hair follicles of the P85 YAP2-5SA-DC trans-
genic mice. The hair germ is a transient structure present
between the dermal papilla and hair follicle bulge during late
catagen/telogen and is thought to be populated by hair follicle
bulge stem/progenitor cells (Chase et al., 1951; Panteleyev
et al., 2001; Ito et al., 2004; Schmidt-Ullrich and Paus, 2005;
Greco et al., 2009). We performed co-immunostaining assays
with antibodies against P-Cadherin, which is highly expressed
in the hair germ and in the hair follicle bulge in late catagen/
telogen hair follicles (Muller-Rover et al., 1999; Greco et al.,
2009), and CD34, which exclusively marks hair follicle bulge
stem/progenitor cells and not hair germ cells (Trempus et al.,
2003; Greco et al., 2009). In P85 wild-type mice, we detected
P-Cadherin at high levels in the hair germ and in the bulge of
late telogen/catagen hair follicles, whereas CD34 was
exclusively expressed in the hair follicle bulge (Figure 5o),
which is consistent with previous reports (Muller-Rover et al.,
1999; Trempus et al., 2003; Greco et al., 2009). In contrast, in
the expanded proximal hair follicles of the YAP2-5SA-DC
transgenic mice, CD34 expression fully overlapped with that
of P-Cadherin (yellow signal in Figure 5p). Altogether, these
data suggest that the expanded proximal hair follicles of the
YAP2-5SA-DC transgenic mice exclusively consist of bulge
stem/progenitor cells and lack hair germ cells.
To determine whether hair follicle bulge stem/progenitor
cells produced matrix cells, hair shaft, and inner root sheath in
YAP2-5SA-DC transgenic mice, we performed quantitative
real-time PCR assays and found strongly reduced expression
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Figure 4. Expansion of basal stem/progenitor cells and suprabasal layers in the interfollicular epidermis of YAP2-5SA-DC transgenic mice. Immunostaining
assays on sections of wild-type (a, c, e, g, i, k) and YAP2-5SA-DC transgenic (b, d, f, h, j, l) skin of P85 littermates showing the expression of basal marker K14 (a, b),
spinous cell marker K10 (c, d), granular cell marker involucrin (e, f), cornified layer marker loricrin (g, h), proliferation marker PHH3 (i, j), and basal stem/
progenitor cell marker P63 (k, l). Double arrows in b, d, f, h highlight thickness of the relevant epidermal layers. Arrows in i, j indicate proliferating cells. Arrows in
k, l indicate P63-expressing nuclei. Basement membranes are demarcated by dashed lines. DAPI, 40,6-diamidino-2-phenylindole; PHH3, phospho-histone H3.
Scale bars¼ 100mm.
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levels of hair matrix markers Lef1 and Msx2 in the P85 YAP2-
5SA-DC transgenic epidermis (Po0.05; n¼3, Figure 5q;
Reginelli et al., 1995; Zhou et al., 1995). In addition,
differentiation markers of the hair shaft (AE13) and inner root
sheath (trichohyalin, AE15) were strongly reduced at P49
(Po0.05; n¼ 3, Figure 5q) and undetectable at P85
(Po0.05; n¼3, data not shown) in the skins of YAP2-5SA-DC
transgenic mice, demonstrating complete loss of hair follicle
differentiation, consistent with the observed alopecia
(Figure 3j).
Finally, we wanted to investigate whether the dermal
papilla, which controls hair cycle activation (Gat et al.,
1998; Van Mater et al., 2003; Lo Celso et al., 2004; Lowry
et al., 2005; Rendl et al., 2008; Zhang et al., 2008c), had a
role in the observed abnormalities. Alkaline phosphatase
staining was used to depict dermal papilla in the epidermis
from animals at P10, P49, and P85 (Figure 5t–y). Though the
dermal papillae were present at P85 at the proximal tip of the
abnormal hair follicles, these structures were not enveloped by
the matrix cells, as in either wild-type littermates or at earlier
developmental stages (Figure 5w with Figure 5r–v). These
results suggest that it is not the lack of the dermal papillae but
rather, perhaps, the aberrant signaling from this center that
underlies the abnormal growth pattern of the hair follicle in
the P85 YAP2-5SA-DC transgenic mice.
The C-terminus of YAP is dispensable for cell proliferation
in vivo
Interestingly, the changes in skin morphology in our YAP2-
5SA-DC postnatal mice seem to represent a ‘‘gain-of-function’’
rather than a ‘‘loss-of-function’’ phenotype, as we had antici-
pated on the basis of in vitro results previously obtained with
this mutant YAP (Hoshino et al., 2006; Zhao et al., 2007).
Indeed, the hyperproliferative phenotype of the basal and
suprabasal epidermal stem/progenitor cell populations that we
observed with the overexpression of YAP2-5SA-DC was also
reported in lines of inducible transgenic mice, in which a
constitutively active full-length YAP mutant (YAPS127A) was
expressed in the progenitor cell population of the epidermis
(Schlegelmilch et al., 2011; Zhang et al., 2011a). In contrast,
conditional mutant mice that either lack the Yap gene or
express a YAP(S79A) mutant, which is incapable of binding
TEAD cofactors in the epidermis, display a severely thinned
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Figure 5. Expansion of hair follicle bulge stem/progenitor cell population in
YAP2-5SA-DC transgenic mice. Immunostaining (a–p), quantitative real-time
reverse transcriptase–PCR (q), and alkaline phosphatase staining assays (r–w)
on the epidermis of wild-type and YAP2-5SA-DC transgenic littermates
showing the expression of outer root sheath marker Keratin 14 (a, b),
companion layer marker K6 (c, d), proliferation marker PHH3 (e, f), bulge
stem/progenitor cell markers K15 (g, h), SOX9 (i, j), LHX2 (k, l), and CD34
(m, n), P-Cadherin and CD34 (o, p), and the location of the dermal papilla
(r–w). (q) Quantitative real-time reverse transcriptase–PCR assays show the
expression levels of hair matrix markers Lef1 and Msx2, inner root sheath
marker AE13, and hair shaft marker AE15 in the epidermis of wild-type and
YAP2-5SA-DC transgenic littermates. Arrows in e, f indicate dividing cells.
Double arrows in g–b highlight size of the hair follicle bulge region. Arrow in o
indicates the hair germ. (q) y Axis displays relative fold expression levels with
the expression levels in wild-type set to 1. Error bars represent mean±SEM
(N¼ 3). Asterisks indicate statistically significant differences in gene expression
levels (Po0.05). Arrows in r–w indicate location of the dermal papilla. Asterisk
mark hair shafts. Basement membranes are demarcated by dashed lines. AP,
alkaline phosphatase; DAPI, 40,6-diamidino-2-phenylindole; mRNA,
messenger RNA; NFR, nuclear fast red; PCAD, P-Cadherin; PHH3, phospho-
histone H3; tg, transgenic; wt, wild-type. Scale bars¼ 100mm.
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epidermis (Schlegelmilch et al., 2011). These data suggest that
YAP2-5SA-DC may still retain its full capacity to bind TEAD
cofactors through intact regions in the N-terminus and to
activate target gene transcription and cell proliferation.
To test this hypothesis, we sought to determine whether
deletion of the C-terminus of YAP affected its ability to
complex with TEAD by conducting immunoprecipitation
studies in vitro. HEK293 cells were cotransfected with HA-
TEAD2 and either Flag-YAP, Flag-YAP-DC, or control plas-
mids. Cell lysates were incubated with mouse anti-Flag
conjugated beads and immunoblotting was performed with
rabbit anti-HA and anti-Flag antibodies. We found that TEAD2
interacted with both YAP and YAP-DC proteins with compar-
able affinity (top blot, Figure 6a), showing that even in the
absence of its C-terminus, YAP can still interact with TEAD
transcription factors.
To test whether YAP2-5SA-DC was still able to activate
transcription of known YAP/TEAD target genes in vivo, we
performed quantitative real-time reverse transcriptase–PCR
assays to determine the relative expression levels of direct
target genes of YAP/TEAD in Keratin 5-expressing cells in the
epidermis of P85 wild-type and YAP2-5SA-DC transgenic
mice. We found that the expression of the two target genes,
glioma-associated oncogene family zinc finger 2 (Gli2) (Zhao
et al., 2008; Fernandez et al., 2009) and Inhibin beta-A Zhang
et al., 2008a; Zhao et al., 2008) were upregulated B3-fold
(Po0.05; n¼ 3, Figure 6b) and 5-fold (Po0.05; n¼3,
Figure 6c), respectively. In addition, we detected GLI2 protein
in the hyperproliferative stem/progenitor cells in the interfolli-
cular epidermis and hair follicles of P85 YAP2-5SA-DC skin
(Figure 6d and e).
These data, together with the observed increased cell
proliferation rates in the epidermis of the YAP2-5SA-DC
transgenic mice, lead us to conclude that the YAP/TEAD
complex does not depend on YAP regions C-terminal of Q281
in vivo (including the YAP transactivation domain and a
PDZ-binding motif) to activate the transcription of target
genes, which control cell proliferation in epidermal stem/
progenitor cell populations. Our conclusion is consistent with
recent evidence that the Drosophila melanogaster YAP ortho-
log, Yorkie, which has a vastly disparate C-terminus, but
highly conserved TEAD-binding and WW domains, is capable
of driving tissue growth in Drosophila melanogaster and in
mice (Dong et al., 2007; Hilman and Gat, 2011). Moreover, a
recent report shows that the C-termini of YAP and Yorkie are
indeed dispensable for their ability to drive cell transformation
in vitro and tissue growth in vivo, respectively (Zhang et al.,
2012).
In contrast to the reported loss of differentiated epidermal
cell types in the interfollicular epidermis of YAPS127A
transgenic mice (Schlegelmilch et al., 2011; Zhang et al.,
2011a), we instead observed thickening of the spinous and
granular cell layers, and hyperkeratinization in the inter-
follicular epidermis of postnatal YAP2-5SA-DC transgenic
mice (Figure 4c–h). In addition, Hes1 mRNA expression levels
were unchanged in the skin of YAP2-5SA-DC transgenic mice
compared with the wild-type mice (data not shown). In
contrast, Zhang et al. (2011a) reported reduced HES1 expres-
sion levels in the interfollicular epidermis of YAPS127A
transgenic mice, indicative of a reduced fate switch between
undifferentiated basal progenitors and spinous cells. These
results suggest that the C-terminus of YAP (from Q281)
may control the balance between epidermal stem/progenitor
cell proliferation and differentiation in the interfollicular
epidermis.
In the YAP2-5SA-DC transgenic mice, hair follicles initially
form and undergo first postnatal anagen relatively normally,
but in subsequent stages, the K15/SOX9/LHX2/CD34-expres-
sing hair follicle stem/progenitor bulge start to proliferate and
form abnormal and massively expanded cell masses, which
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the interfollicular epidermis. Single arrows indicate location of the hair follicle bulge. Basement membranes are demarcated by dashed lines. CON, control; DAPI,
40,6-diamidino-2-phenylindole; GLI2, glioma-associated oncogene family zinc finger 2; IB, immunoblot; Inhba, inhibin beta-A; IP, immunoprecipitation;
SG, sebaceous gland; YAP, yes-associated protein. Scale bars¼ 100mm.
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fail to differentiate. Ultimately these defects lead to alopecia.
Conceivably, this phenotype is caused by a failure to correctly
respond to regulatory signals emanating from the dermal
papilla. In contrast to the YAPS127A transgenic mice
described by Zhang et al. (2011a), we did not observe signs
of evaginating hair follicles at any stage in the postnatal YAP2-
5SA-DC transgenic epidermis. This may be explained by the
later onset of transgene expression, given no grossly abnormal
epidermal phenotype was visible at around birth. The
expression patterns of bulge stem/progenitor cell markers
and the loss of hair follicle differentiation markers in YAP2-
5SA-DC transgenic skin, however, were consistent with the
reported expression of these markers in late embryonic and
newborn YAPS127A transgenic hair follicles (Zhang et al.,
2011a).
In summary, we show that YAP functions independently of
its C-terminal domain as a molecular switch to control
epidermal stem/progenitor cell proliferation in vivo. YAP is
now emerging as a potential therapeutic target for skin cancer,
psoriasis, and degenerative skin diseases such as epidermo-
lysis bullosa.
MATERIALS AND METHODS
Generation of transgenic mice
Protocols and use of animals in the described experiments were
approved by the Animal Welfare Unit of the University of Queensland,
which is registered as an institution that uses animals for scientific
purposes under the Queensland Animal Care and Protection Act
(2001). Yap complementary DNA encoding the mutant YAP2 protein
‘‘YAP2-5SA-DC’’ (provided by Professor Kun-Liang Guan) (Zhao et al.,
2007) was cloned into the NheI and SnaBI restriction sites of the
transgenic vector containing 5.2 kb 50-regulatory sequences of the
bovine Keratin 5 gene (provided by Angel Ramirez (Ramirez et al.,
1994)). The 6.1 kb transgenic fragment was released using Kpn1 and
microinjected into the pronuclei of zygotes of (C57BlCBA) F1 hybrid
mice. Founders were identified by PCR genotyping of genomic tail
DNA using forward primer 50-TGGGCTGGGAAGGTGTCCATTTGC-30
and reverse primer 50-CACTGGTGTTGGGAGAAGCAGCA-30 that
amplify a 992 bp fragment unique to the pBK5-YAP transgenic
vector. Founders were intercrossed with C57Bl mice for the
generation of transgenic founder lines. Transgenic mice were
creamed with Derisal daily, which reduced the skin lesions, but did
not affect the phenotypic abnormalities.
Tissue preparation and embedding
Newborn and adult mice were killed by decapitation and cervical
dislocation, respectively. Dorsal skin was dissected and immersion
fixed for 15 hours at 4 1C in Tellyesniczky/Fekete solution (70% EtOH
containing 5% glacial acetic acid and 10% formalin). Subsequently,
tissue was dehydrated in EtOH and xylene series and processed for
paraffin embedding using routine histology methods. Paraffin sections
(8–10mm) were cut, collected on Superfrost Plus glass slides, and
stored at room temperature.
Histological staining, immunostaining, and alkaline phosphatase
staining assays
Paraffin sections were first rehydrated and stained with haematoxylin/
eosin using common histological staining protocols. Immuno-
histochemistry was performed as previously described (St John
et al., 2006). For immunofluoresence, sections were blocked in 2%
BSA (Sigma Chemical Corporation, Castle Hill, NSW, Australia) in
0.1 M tris-buffered saline (pH 7.2) with 0.3% Triton-X-100 for
30 minutes at room temperature. The sections were incubated
overnight at 4 1C with primary antibodies diluted in 2% BSA and
0.3% TX-100 in tris-buffered saline, washed with tris-buffered saline/
Triton-X-100, and incubated with the appropriate secondary
antibodies in the dark for 2 hours at room temperature. Sections
were counterstained with 40,6-diamidino-2-phenylindole and
examined using an Olympus BX61 upright confocal microscope (Mt
Waverley, VIC, Australia). The following antibodies were used: anti-
Yap (1:200; Abcam ab39361, Waterloo, NSW, Australia), anti-Yap
phospho S127 (1:100, Abcam ab76252), anti-Keratin 14 (1:1000;
Covance PRB-155P, North Ride, NSW, Australia), anti-Keratin 10
(1:500; Covance PRB-159P), anti-involucrin (1:500; Covance PRB-
140C), anti-loricrin (1:500; Covance PRB-145P), anti-Keratin 6
(1:200; Covance PRB-169P), anti-Keratin 15 (1:500; Covance PCK-
153P), anti-SOX9 (1:100; Santa Cruz, Santa Cruz, CA, sc-20095),
anti-LHX2 (1:50; Santa Cruz, sc-19344), anti-P63 (1:200; Santa Cruz
sc-8343), anti-phospho-histon H3 (1:200; Millipore, Temecula, CA,
06-570), goat anti-P-Cadherin (1:50; R&D, Waterloo, NSW, Australia,
Systems AF761), rat anti-CD34 (1:30, kindly provided by Prof. E.
Dejana, IFOM, Milan, Italy), anti-GLI2 (1:100; Abcam ab7195), goat
anti-Rabbit-Alexa 594 (1:200; Molecular Probes, Eugene, OR,
A-11012), goat anti-Chicken-Alexa 594 (1:200; Molecular Probes
A-11042), rabbit anti-rat Alexa 594 (1:200, Molecular Probes
A-21211), and biotinylated goat anti-rabbit Ig antibodies (1:400,
Vector Laboratories, Burlingame, CA).
For alkaline phosphatase staining, sections were incubated with the
alkaline phosphatase substrate, nitro-blue tetrazolium chloride/5-
bromo-4-chloro-3’-indolyphosphate p-toluidine salt (Roche), for
30 minutes at room temperature and counterstained with Nuclear
Fast Red solution (Sigma, Castle Hill, NSW, Australia).
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were performed as
described previously (Zhang et al., 2009). Briefly, Flag-YAP, Flag-
YAP-DC (Zhang et al., 2012), or control empty vector plasmids were
transfected into HEK-293T cells, together with HA-tagged TEAD2.
Cells were lysed after 48 hours and immunoprecipitated with anti-
Flag agarose beads (Sigma). Immunoprecipitates were separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
immunoblotted with anti-Flag (Sigma) or anti-HA (Santa Cruz).
Quantitative real-time PCR assays
Total RNA was extracted from dissected P85 using the RNeasy Mini
kit (QIAGEN, Chadstone Centre, VIC, Australia) according to the
manufacturer’s instructions, including on-column DNase digestion.
Total RNA was reverse-transcribed with random primers (Promega,
South Sydney, NSW, Australia) and Superscript III (Invitrogen,
Carlsbad, CA) using standard methodologies. Quantitative real-time
reverse transcriptase–PCR primers were designed with melting tem-
perature (Tm) of close to 60 1C to generate 60–145 bp amplicons:
Gli2-F: 50-GCAGACTGCACCAAGGAGTA-30, Gli2-R: 50-CGTGGA
TGTGTTCATTGTTGA-30, Inhibin beta-A-F: 50-ATCATCACCTTTGCC-
GAGTC-30, Inhibin beta-A-R: 50-TCACTGCCTTCCTTGGAAAT-30,
Keratin 5-F: 50-CAGAGCTGAGGAACATGCAG-30, Keratin 5-R: 50CA
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TTCTCAGCCGTGGTACG-30, AE13-F: 50-CCATTGAAGAACTCCAA
CAAAA-30, AE13-R: 50-GCAGTTGTCCACCTGAACG-30, AE15-F: 50-
GAGCTAAGACGCGAGCAAGA-30, AE15-R: 50-CCACCTCTGGGTA
ATGCTCT-30, Lef1-F: 50-TCCTGAAATCCCCACCTTCT-30, Lef1-R: 50-
TGGGATAAACAGGCTGACCT-30, Msx2-F: 50-AGGAGCCCGGCA
GATACT-30, Msx2-R: 50-GTTTCCTCAGGGTGCAGGT-30, 18S-F: 50-
GATCCATTGGAGGGCAAGTCT-30, 18S-R: 50-CCAAGATCCAACTA
CGAGCTTTTT-30. Quantitative real-time reverse transcriptase–PCR
assays were carried out using SYBR green PCR master mix and an ABI
PRISM 7500 Sequence Detection System. Target complementary
DNA levels were analyzed by the comparative cycle time method
and values were normalized to 18S ribosomal RNA expression levels.
Statistical significance of changes in relative gene expression was
assessed by a Student’s paired t-test with a one-tailed distribution.
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